Annals of Pharmacotherapy

作为投稿流程的一部分，作者将被要求列出每位作者的贡献，并在致谢部分之后加入作者贡献标题；所有作者必须符合作者资格标准、审阅并批准论文，且作者身份基于对以下各项的实质性贡献。 模型中文摘要

You will be asked to list the contribution of each author as part of the submission process. Please include the Author Contributions heading within your submission after the Acknowledgements section. The information you give on submission will then show under the Author Contributions heading later at the proofing stage. Criteria for Authorship All authors must have fulfilled the criteria for autho…

该期刊致力于促进研究的开放性、透明度和可重复性，鼓励作者在符合伦理和法律要求的前提下，将研究数据存入相关公共数据仓库、提供链接数据的数据可用性声明（如无法共享则说明原因）并在研究中引用该数据。 模型中文摘要

The Journal is committed to facilitating openness, transparency and reproducibility of research, and has the following research data sharing policy. For more information, including FAQs please visit the Sage Research Data policy pages. Subject to appropriate ethical and legal considerations, authors are encouraged to: Share your research data in a relevant public data repository Include a data ava…

作者应在指定标题下提供伦理批准声明（即使方法部分已包含），如无需伦理批准须明确说明；报告涉及人类参与者、人类数据或人体组织的研究必须声明相关伦理委员会或机构审查委员会批准或豁免，并提供委员会全称、所属机构及批准编号。 模型中文摘要

Please include your ethics approval statements under this heading, even if you have already included ethics approval information in your methods section. If ethical approval was not required, you need to explicitly state this. All papers reporting studies involving human participants, human data or human tissue must state that the relevant Ethics Committee or Institutional Review Board approved th…

该期刊投稿或发表无需付费，彩色图在线发表免费，但印刷版彩色图第一页收费800美元、之后每页200美元；作者可通过Sage Choice计划或开放获取协议付费选择开放获取出版，费用视协议而定可享折扣或免费。 模型中文摘要

There are no fees payable to submit or publish in this journal. Figures submitted in color will be published in color in the online version of the journal at no cost. If you wish to have color figures in the printed version, the following fees apply: To print figures in color there is a cost to the authors of $800 for the first page and $200 for each additional page. Optional open access publishin…

该期刊采用双匿名同行评审，稿件先经初步评估，不符合指南要求的稿件将被退回修改，超出范围或不合适的稿件可能未经同行评审即被直接拒稿，通过初评后进入同行评审。 模型中文摘要

The following summary describes the peer review process for this journal: Identity transparency: Double Anonymized Reviewer interacts with: Editor Review information published: None Your manuscript will undergo an initial evaluation. If it does not conform to the requirements laid out in these guidelines, it will be returned to you for amendments prior to peer review. Manuscripts may be desk rejec…

期刊和Sage非常重视版权侵权、抄袭或其他违反出版最佳实践的行为，请阅读Sage关于抄袭的完整政策及可能采取的措施。 模型中文摘要

The journal and Sage take issues of copyright infringement, plagiarism or other breaches of best practice in publication very seriously. Please read Sage's complete policy on plagiarism and the actions we may take.

该期刊接受曾在预印本服务器发布的稿件，投稿时须在指定字段填写预印本DOI，建议投稿时告知编辑部已发布的预印本，且在同行评审期间不应在预印本服务器发布更新版本。 模型中文摘要

The journal will consider submissions of manuscripts that have been posted on preprint servers. Please enter the preprint DOI in the designated field when submitting your manuscript. We advise that you inform the Journal Editorial office about your posted preprint at submission. Note that you should not post an updated version of your manuscript on a preprint server while it is being peer reviewed…

该期刊遵循ICMJE要求，临床试验须在首个受试者入组时或之前在WHO认可的公共试验注册机构注册，作为考虑发表的先决条件，且试验注册机构名称、网址和注册号必须列在摘要末尾。 模型中文摘要

The journal conforms to the ICMJE requirement that clinical trials are registered in a WHO-approved public trials registry at or before the time of first participant enrollment as a condition of consideration for publication. The trial registry name and URL, and registration number must be included at the end of the abstract.